MD Anderson Cancer Center
General Surgery
Dr. Elizabeth Mittendorf, MD
|
|
Give Review
Dr. Elizabeth Mittendorf is an expert in the field of General Surgery. She went to medical school at Case Western Reserve University School of Medicine. She over the years received 1 awards: "Fellow (FACS)". Elizabeth Mittendorf is a published doctor. She published 103 publications, including: 'Anomalous vertebral artery anatomy and the consequences of penetrating vascular injuries.' She is registered with Medicare and accepts Medicare payments.
Publications
- Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Work...
- Obese Women Experience Fewer Complications after Oncoplastic Breast Repair following Partial Mastectomy Than after Immediate Total Breast Reconstruction.
- Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.
- Adjuvant HER2/neu peptide cancer vaccines in Breast cancer.
- Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
- Reply to L. Antolini et al.
- Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for Breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
- Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.
- Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Tr...
- Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer.
- Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer: A Prospective Feasibility Trial.
- Peptide-Based Vaccination and Induction of CD8+ T-Cell Responses Against Tumor Antigens in Breast Cancer.
- Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes.
- Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: Findings From the A...
- Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer.
- Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in C...
- Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer.
- The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in Breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.
- PD-L1 Expression in Triple-Negative Breast Cancer.
- The Controversy Regarding Margin Width in Breast Cancer: Enough is Enough.
- Which threshold for ER positivity? A retrospective study based on 9639 patients.
- Immune checkpoints: A therapeutic target in triple negative Breast cancer.
- Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.
- Incidence and consequence of close margins in patients with ductal Carcinoma-in situ treated with mastectomy: is further therapy warranted?
- The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in Breast Cancer: Where Are We Now?
- Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive Breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
- Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients.
- Clinical Course of Breast Cancer Patients with Isolated Sternal and Full-Thickness Chest Wall Recurrences Treated With and Without Radical Surgery.
- Immune aspects of the Breast tumor microenvironment.
- Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy.
- Cancer immunotherapies, their safety and toxicity.
- Landmark trials affecting the surgical management of invasive Breast cancer.
- Impact of chemotherapy sequencing on local-regional failure risk in Breast cancer patients undergoing Breast-conserving therapy.
- A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
- Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population.
- Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III Breast cancer.
- Biology, treatment, and outcome in very young and older women with DCIS.
- American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns.
- Changing Behavior in Clinical Practice in Response to the ACOSOG Z0011 Trial: A Survey of the American Society of Breast Surgeons.
- The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer.
- Crossover Effects of Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race.
- Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillanc...
- Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial.
- Anomalous vertebral artery anatomy and the consequences of penetrating Vascular injuries.
- The Drosophila maternal effect locus deadhead encodes a thioredoxin homolog required for female meiosis and early embryonic development.
- Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision.
- Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in Breast cancer patients with a positive sentinel l...
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors.
- Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current...
- Triple-negative Breast cancer is not a contraindication for Breast conservation.
- Locoregional treatment of Breast cancer: where to next?
- AE37: a novel T-cell-eliciting vaccine for Breast cancer.
- Local-Regional Recurrence With and Without Radiation Therapy after Neoadjuvant Chemotherapy and Mastectomy for Clinically Staged T3n0 Breast Cancer.
- Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy.
- Age and Survival Estimates in Patients Who Have Node-Negative T1ab Breast Cancer by Breast Cancer Subtype.
- Response to the Letter to the Editor: Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOS...
- Breast cancer vaccines: ongoing National Cancer Institute-registered clinical trials.
- Management of local-regional recurrence following immediate Breast reconstruction in patients with early Breast cancer treated without postmastectomy radiotherapy.
- Delays in Primary Surgical Treatment Are Not Associated with Significant Tumor Size Progression in Breast Cancer Patients.
- Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy.
- Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death.
- Comparison of different HER2/neu vaccines in adjuvant Breast cancer trials: implications for dosing of peptide vaccines.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- Folate receptor α: A storied past and promising future in immunotherapy.
- Sentinel lymph node dissection is technically feasible in older Breast cancer patients.
- Impact of progression during neoadjuvant chemotherapy on surgical management of Breast cancer.
- Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive Breast cancer patients: experience f...
- Does blue dye contribute to success of sentinel node mapping for Breast cancer?
- Controversies in Breast surgery.
- Use of booster inoculations to sustain the clinical effect of an adjuvant Breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and...
- Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the Breast.
- Factors affecting the decision of Breast cancer patients to undergo contralateral prophylactic mastectomy.
- Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive Breast...
- A novel interaction between HER2/neu and cyclin E in Breast cancer.
- Use of GM-CSF as an adjuvant with Cancer vaccines: beneficial or detrimental?
- Present-day locoregional control in patients with t1 or t2 Breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in Breast cancer patients.
- Predictors of tumor progression during neoadjuvant chemotherapy in Breast cancer.
- Clinicopathologic factors associated with involved margins after Breast-conserving surgery for invasive lobular carcinoma.
- Mechanisms of T-cell inhibition: implications for Cancer immunotherapy.
- Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free Breast cancer patients: United States Military Cancer Institute Clin...
- Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.
- Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in Breast cancer patients.
- Lymphatic interrupted: do we really understand the risks and consequences?
- The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
- Gamma probe identification of normal parathyroid glands during central neck surgery can facilitate parathyroid preservation.
- CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37).
- Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage Breast cancer pa...
- Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent Breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01...
- Staging of Breast cancer in the neoadjuvant setting.
- Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
- The E75 HER2/neu peptide vaccine.
- Monitoring circulating tumor cells in Cancer vaccine trials.
- Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from U...
- Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk Breast cancer patients: U.S. Military Cancer Institute Clinic...
- Melanoma adrenal metastasis: natural history and surgical management.
- Combined use of clinical and pathologic staging variables to define outcomes for Breast cancer patients treated with neoadjuvant therapy.
- Electrical impedance scanning as a new Breast cancer risk stratification tool for young women.
- Significance and management of micrometastases in patients with Breast cancer.
- An elderly woman with primary hyperparathyroidism exhibits improvement of neurocognitive dysfunction after parathyroidectomy.
- Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (...
- Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of...
Schools
Case Western Reserve Univ Sch Of Med
Cwru University Hospital
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Breast Cancer
- Breast Lump
- Carcinoma in Situ
- Crohn's Disease (Regional Enteritis)
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Case Western Reserve University - University Hospitals -
Case Western Reserve University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831288596 |
| Last Name Of The Provider | MITTENDORF |
| First Name Of The Provider | ELIZABETH |
| View All |
Similar Doctors
|
|
Dr. Robert D. Sasso, MD |
|
|
Dr. Jessica S. Colen, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. William I. Douglas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael K. Lee, MD |
|
Dr. Bob H. Saggi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Guidroz, MD |
|
|
Dr. Stacey A. Carter, MD |
|
|
Dr. Somala Mohammed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna Lakoma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yin Yiu, MD |